Pfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.
Pfizer was the first company to seek emergency-use authorisation (EUA) for a Covid-19 vaccine in India, but the government this month approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research. India s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company s application was made in early December. The regulator has also declined to accept the company s request for approval without a small local trial on the vaccine s safety and immunogenicity for Indians, Reuters has reported.
Pfizer Wants India To Order Covid Vaccine Before Pursuing Approval Pfizer Wants India To Order Covid Vaccine Before Pursuing Approval Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India The data collected has been endorsed by various regulatory agencies, Pfizer said.
Highlights
Drug regulator says Pfizer officials failed to turn up to meetings
Pfizer says its application is supported by data from a global study
New Delhi:
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten.
Pfizer to seek regulatory approval if India places order for COVID-19 vaccine
India s Central Drugs Standard Control Organisation (CDSCO) says Pfizer officials failed to turn up to meetings after the company s application was made in early December
Reuters | January 25, 2021 | Updated 22:27 IST
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.
COVID-19 vaccine update | Pfizer wants India to order coronavirus vaccine before pursuing approval
India s CDSCO says Pfizer officials failed to turn up to meetings after the company s application was made in early December. The regulator has also declined to accept the company s request for approval without a small local trial on the vaccine s safety and immunogenicity for Indians Reuters
Pfizer covid-19 vaccine
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.
2-MIN READ
Pfizer Wants India to Order Covid-19 Vaccine Before Pursuing Approval
A small shopping basket filled with vials labeled COVID-19 - Coronavirus Vaccine and medical sryinges are placed on a Pfizer logo in this illustration. (Reuters)
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots – one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.
FOLLOW US ON:
Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday, even as global supplies tighten.